Pulse Biosciences, Inc Common Stock (DE) (PLSE) is a publicly traded Healthcare sector company. As of May 21, 2026, PLSE trades at $25.66 with a market cap of $1.77B and a P/E ratio of -23.50. PLSE moved +4.49% today. Year to date, PLSE is +78.70%; over the trailing twelve months it is +52.84%. Its 52-week range spans $12.56 to $27.98. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PLSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes PLSE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $25.66 |
| Market Cap | $1.77B |
| P/E Ratio | -23.50 |
| EPS | $-1.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.98 |
| 52-Week Low | $12.56 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $751.00K |
| Net Income | $-74.57M |
| Gross Margin | 0.00% |
2 analysts cover PLSE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.